1

VHH fragments Reactivate tumor suppressor p53: New New Approach for Malignant Management

News Discuss 
A critical advance in cancer research is occurring with the use of nanobodies to re-engage mutated p53. This essential tumor protector protein is frequently disabled in various kinds of malignancies, resulting https://tealbookmarks.com/story21917418/nanobodies-revive-the-p53-protein-the-new-pathway-for-malignant-treatment

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story